Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Assets AverageEnterprise ValueEquity AverageEquity RatioInvested CapitalMarket CapitalizationReturn on AssetsReturn on Capital EmployedReturn on Equity

Contineum Therapeutics (CTNM) Return on Capital Employed: 2024

Historic Return on Capital Employed for Contineum Therapeutics (CTNM) over the last 1 years, with Dec 2024 value amounting to -0.25%.

  • Contineum Therapeutics' Return on Capital Employed was N/A to -0.25% in Q4 2024 from the same period last year, while for Dec 2024 it was -0.25%, marking a year-over-year change of. This contributed to the annual value of -0.31% for FY2024, which is N/A change from last year.
  • According to the latest figures from Q4 2024, Contineum Therapeutics' Return on Capital Employed is -0.25%, which was down 21.75% from -0.20% recorded in Q3 2024.
  • Over the past 5 years, Contineum Therapeutics' Return on Capital Employed peaked at 0.09% during Q1 2024, and registered a low of -0.25% during Q4 2024.
  • Its 1-year average for Return on Capital Employed is -0.15%, with a median of -0.22% in 2024.